Pharmacokinetics of orally administered phenylbutazone in African and Asian elephants (Loxodonta africana and Elephas maximus)

Journal of Zoo and Wildlife Medicine

Volumn 39, Issue 2, 2008, Pages 188-200

  Bechert, Ursula ^a   Christensen, J Mark ^b   Nguyen, C ^b   Neelkant, R ^b   Bendas, E ^b  

^a OREGON STATE UNIVERSITY   (United States)

^b 203 Pharmacy Building   (United States)

Author keywords

African elephants; Asian elephants; NSAID; Pharmacokinetics; Phenylbutazone

Indexed keywords

PHENYLBUTAZONE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; CROSSOVER PROCEDURE; DOSE RESPONSE; ELEPHANT; FEMALE; HALF LIFE TIME; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; RANDOMIZATION; SPECIES DIFFERENCE; ZOO ANIMAL;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, ZOO; AREA UNDER CURVE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELEPHANTS; FEMALE; HALF-LIFE; MALE; PHENYLBUTAZONE; RANDOM ALLOCATION; SPECIES SPECIFICITY;

ELEPHANTIDAE; ELEPHAS MAXIMUS; LOXODONTA; LOXODONTA AFRICANA;

EID: 44649191047     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: 10.1638/2007-0139R.1     Document Type: Article

References (52)

1. Bechert, U., and J. M. Christensen. 2007. Pharmacokinetics of orally administered ibuprofen in African and Asian elephants (Loxodonta africana and Elephas maximus). J. Zoo. Wildl. Med. 38(2): 258-268.
2. Beluche, L. A., A. L. Bertone, D. E. Anderson, and C. Rohde. 2001. Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism. Am. J. Vet. Res. 62(12): 1916-1921.
3. Bengtsson, B., S. Jacobsson, J. Luthman, and A. Franklin. 1997. Pharmacokinetics of penicillin-G in ewes and cows in late pregnancy and in early lactation. J. Vet. Pharmacol. Ther. 20: 258-261.
4. Boothe, D.M. 1989. Controlling inflammation with nonsteroidal anti-inflammatory drugs. Vet. Med. 9: 875-883.
5. Burns, J. J., R. K., Rose, T. Chenkin, S. Goodwin, A. Goldman, A. Schulert, and B. B. Brodie. 1953. The physiological disposition of phenylbutazone (Butazolidin) in man and a method for its estimation in biological material. J. Pharmacol. Exper. Therap. 109: 346-357.
6. Clauss, M., H. Steinmetz, U. Eulenberger, P. Ossent, R. Zingg, J. Hummel, and J. Halt. 2007. Observations on the length of the intestinal tract of African Loxodonta africana (Blumenback 1797) and Asian elephants Elephas maximus (Linne 1735). Eur. J. Wild. Res. 53: 68-72.
7. De Veau, E. J., W. Pedersoli, R. Cullison, and J. Baker. 1998. Pharmacokinetics of phenylbutazone in plasma and milk of lactating dairy cows. J. Vet. Pharmacol. Ther. 21(6): 437-443.
8. Dietzel, K., W. S. Beck, H. T. Schneider, G. Geisslinger, and K. Brune. 1990. The biliary elimination and enterohepatic circulation of ibuprofen in rats. Pharm. Res. 7(1): 87-90.
9. Eeckhoudt, S. L., P. A. Evrard, and R. K. Verbeeck. 1997. Biliary excretion and enterohepatic cycling of R-and S- flurbiprofen in the rat. Drug Metab. Dispos. 25(4): 428-430.
10. Eltom, S. E., C. L. Guard, and W. S. Schwark. 1993. The effect of age on phenylbutazone pharmacokinetics, metabolism and plasma protein binding in goats. J. Vet. Pharmacol. Ther. 16: 141-151.
11. Evans, G. H. 1910. Elephants and Their Diseases. GPO, Rangoon.
12. Foose, T. J. 1982. Trophic Strategies of Ruminant Versus Non-ruminant Ungulates. Ph.D. Dissertation, Univ. Chicago, Chicago, Illinois.
13. Gabel, A. A., T. Tobin, R. S. Ray, and G. A. May-lin. 1977. Phenylbutazone in horses: a review. J. Equine Med. Surg. 1: 221-225.
14. Garcia, R. 1998. Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs. Am. J. Med. 104(3): 30-34.
15. Hackenberger, M. K. 1987. Diet Digestibilities and Ingesta Transit Times of Captive Asian and African Elephants. M.Sc. Thesis, Univ. Guelph, Guelph, Ontario, Canada.
16. Held, H., and C. Enderle. 1976. Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency. Clin. Nephrol. 6(3): 388-393.
17. Hvidberg, E. E, and F. Rasmussen. 1975. Pharmacokinetics of phenylbutazone and oxyphenbutazone in the pig. Can. J. Comp. Med. 39: 80-88.
18. Hunter, R. P., R. Isaza, and D. E. Koch. 2003. Oral bioavailabity and pharmacokinetic characteristics of ketoprofen eneniomers after oral and intravenous administration in Asian elephants (Elephas maximus). Am. J. Vet. Res. 64(1): 109-114.
19. Janhchen, E., and G. Levy. 1972. Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone. Proc. Soc. Exp. Biol. Med. 141: 963-965.
20. Kore, A. M. 1990. Toxicology of nonsteroidal antiinflammatory drugs. Vet. Clin. N. Am. (Sm. Ani. Pract.) 20(2): 419-431.
21. Lees, P., T. Ayliffe, T. E. Maitho, and J. B. Taylor. 1988. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration. Res. Vet. Sci. 44: 57-67.
22. Lees, P., and A. J. Higgins. 1985. Clinical pharmacology and therapeutic uses of non-steroidal anti-inflammatory drugs in the horse. Equine Vet. J. 17: 83-96.
23. Lees, P., T. E. Maihto, and J. B. Taylor. 1985. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study. Vet. Rec. 116: 229-232.
24. Lees, P., J. B. Taylor, T. E. Maitho, J. D. Millar, and A. J. Higgins. 1987. Metabolism excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse. Cornell Vet. 77(2): 192-211.
25. Leung, B. S., J. R. Pearson, and R. P. Martin. 1975. Enterohepatic cycling of 3H-estrone in the bull: identification of estrone-3-glucuronide. J. Steroid. Biochem. 6(11-12): 1477-1481.
26. Lodwick, L. J., J. M. Dubach, L. G. Phillips, C. S. Brown, and M. A. Jandreski. 1994. Pharmacokinetics of amikacin in African elephants (Loxodonta africana). J. Zoo Wildl. Med. 25: 367-375.
27. Mahmood, I., M. Martinez, and R. P. Hunter. 2006. Interspecies allometric scaling. Part I: prediction of clearance in large animals. J. Vet. Pharm. Therap. 29: 415-423.
28. Maihto, T. E., P. Lee, and J. B. Taylor. 1986. Absorption and Pharmacokinetics of phenylbutazone in Welsh Mountain Ponies. J. Vet. Pharmacol. Ther. 9: 26-39.
29. Martin, R. P., D. L. Loriaux, and G. S. Farnham. 1965. Enterohepatic cycling of metabolized testosterone in the male dog. Steroids 2: 149-163.
30. Mikota, S. K., E. L. Sargent, and G. S. Ranglack. 1994. Medical Management of the Elephant. Indira Pub-lishing House, West Bloomfield, Michigan. Pp. 137-150.
31. Mortenson, J., and S. Sierra. 1998. Determining dosages for anti-inflammatory agents in elephants. Proc. Am. Assoc. Zoo. Vet. Pp. 477-479.
32. Navarre, C. B., W. R. Ravis, R. Nagilla, A. Simpkins, S. H. Duran, and D. G. Pugh. 2001. Pharmacokinetics of phenylbutazone in llamas following single intravenous and oral doses. J. Vet. Pharmacol. Therap. 24: 227-231.
33. Ollivet-Courtois, E, A. Lecu, R. A. Yates, and L. H. Spelman. 2003. Treatment of a sole abscess in an Asian elephant (Elephas maximus) using regional digital intravenous perfusion. J. Zoo Wildl. Med. 34(3): 292-295.
34. Page, C. D., M. Mautino, H. D. Derendorf, and J. P. Anhalt. 1991. Comparative pharmacokinetics of trimethoprim-sulfamethoxazole administered intravenously and orally to captive elephants. J. Zoo Wildl. Med. 22: 409-416.
35. Perrier, D., J. J. Ashley, and G. Levy. 1973. Effect of product inhibition on kinetics of drug elimination. J. Pharmacokin. Pharmacodyn. 1(3): 231-242.
36. Piperno, E., D. J. Ellis, S. M. Getty, and T. M. Brody. 1968. Plasma and urine levels of phenylbutazone in the horse. J. Am. Vet. Med. Assoc. 153(2): 195-198.
37. Ploeger, B., T. Mensinga, A. Sips, J. Meulenbelt, and J. DeJongh. 2000. A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Pharm. Res. 17(12): 1516-1525.
38. Ramirez, S. 1997. Duration of effects of phenylbutazone on serum total thyroxine and free thyroxine concentrations in horses. J. Vet. Int. Med. 11(6): 371-374.
39. Reed, S., I. Messer, T. Nathaniel, R. Tessman, and K. Keegan. 2006. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. Am. J. Vet. Res. 67(3): 398-402.
40. Roberts, M. S., B. M. Magnusson, F. J. Burczynski, and M. Weiss. 2002. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Chin. Pharm. 41(10): 751-790.
41. Sedgewick, C. J. 1993. Allometric scaling and emergency care: the importance of body size. In: Fowler, M. E. (ed.). Zoo and Wild Animal Medicine, 3rd ed. W. B. Saunders, Philadelphia, Pennsylvania. Pp. 34-37.
42. Semrad, S. D., J. T. McClure, R. A. Sams, and L. M. Kaminiski. 1993. Pharmacokinetics and effects of repeated administration of phenylbutazone in neonatal calves. Am. J. Vet. Res. 54: 1906-1911.
43. Shoshoni, J., and 76 co-authors. 1982. On the dissection of a female Asian elephant (Elephas maximus) and data from other elephants. Elephant 2: 3-93.
44. Stevens, C. S., and I. D. Hume. 1995. Comparative Physiology of the Vertebrate Digestive System. Cambridge University Press, New York, New York.
45. Sullivan, M., and D. H. Snow. 1982. Factors affecting absorption of non-steroidal anti-inflammatory agents in the horse. Vet. Red. 110: 554-558.
46. Tobin, T., S. Chay, S. Kamerling, W. E. Woods, T. J. Weckman, J. W. Blake, and P. Lees. 1986. Phenylbutazone in the horse: a review. J. Vet. Pharmacol. Then 9(1): 1-25.
47. United States Pharmacopeia. 2004. The National Formulary. The U.S. Pharmacopeial Convention, Inc., Rockville, Maryland. Pp. 1-14.
48. Vree, T. B., and C. J. Timmer. 1998. Enterohepatic cycling and pharmacokinetics of oestradiol in postmenopausal women. J. Pharm. Pharmacol. 50(8): 857-864.
49. Williams, R. J., F. D. Boudinot, J. A. Smith, and A. P. Knight. 1990. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after mul tiple oral dosing. Am. J. Vet. Res. 51(3): 367-370.
50. Wilson, K. 1984. Sex-related differences in drug disposition in man. Clin. Pharm. 9: 189-202.
51. Witkamp, R. F, H. I. Yun, G. A. van't Klooster, J. F. Mosel, M. van Mosel, J. M. Ensink, J. Noordhoek, and A. S. van Miert. 1992. Comparative aspects and sex differentiation of plasma sulfamethazine elimination and metabolite formation in rats, rabbits, dwarf goats, and cattle. Am. J. Vet. Res. 53: 1830-1835.
52. Zhou, H. W, J. Q. Shen, M. Lu, W. Q. Liang, W. Lin, and W. H. Zhao. 1992. Pharmacokinetic analysis of enterohepatic circulation of piroxicam in rabbits. Acta Pharmacol. Sinica 13(2): 180-182.